Acute phase reaction following intravenous administration of streptokinase.
D000328:Adult; D000368:Aged; D001609:Beta-Globulins / Q000032:analysis; D002097:C-Reactive Protein / Q000032:analysis; D002570:Ceruloplasmin / Q000032:analysis; D005340:Fibrinogen / Q000032:analysis; D005342:Fibrinolysis; D006801:Humans; D007275:Injections, Intravenous; D008875:Middle Aged; D009203:Myocardial Infarction / Q000188:drug therapy; D009961:Orosomucoid / Q000032:analysis; D010958:Plasminogen / Q000032:analysis; D013300:Streptokinase / Q000008:administration & dosage* / Q000494:pharmacology; D013924:Thrombophlebitis / Q000188:drug therapy; D013997:Time Factors; D000515:alpha 1-Antitrypsin / Q000097:blood
D001609:Beta-Globulins; D009961:Orosomucoid; D000515:alpha 1-Antitrypsin; D005340:Fibrinogen; D010958:Plasminogen; D002097:C-Reactive Protein; D002570:Ceruloplasmin; D013300:Streptokinase